Cytosorbents Crp Total Assets Over Time
| CTSO Stock | USD 0.93 0.01 1.09% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Cytosorbents Crp Performance and Cytosorbents Crp Correlation. Cytosorbents |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytosorbents Crp. If investors know Cytosorbents will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytosorbents Crp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.36) | Revenue Per Share 0.72 | Quarterly Revenue Growth 0.066 | Return On Assets (0.28) | Return On Equity (1.19) |
The market value of Cytosorbents Crp is measured differently than its book value, which is the value of Cytosorbents that is recorded on the company's balance sheet. Investors also form their own opinion of Cytosorbents Crp's value that differs from its market value or its book value, called intrinsic value, which is Cytosorbents Crp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytosorbents Crp's market value can be influenced by many factors that don't directly affect Cytosorbents Crp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytosorbents Crp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytosorbents Crp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytosorbents Crp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Total Assets Analysis
Compare Cytosorbents Crp and related stocks such as ProSomnus, Common Stock, LivaNova PLC, and Electromed Total Assets Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LIVN | 25.2 M | 211.9 M | 264 M | 294.2 M | 315.9 M | 2.6 B | 2.3 B | 2.5 B | 2.5 B | 2.4 B | 2.4 B | 2.2 B | 2.3 B | 2.4 B | 2.6 B |
| ELMD | 9.4 M | 20.9 M | 17.6 M | 15.8 M | 17.4 M | 20.6 M | 23.1 M | 26.6 M | 29.4 M | 33.2 M | 37.1 M | 41.4 M | 45.8 M | 52.2 M | 28.3 M |
| KIDS | 35.8 M | 35.8 M | 35.8 M | 35.8 M | 35.8 M | 30.7 M | 30.7 M | 82.3 M | 112.1 M | 194.6 M | 320.4 M | 304.3 M | 427.7 M | 438.7 M | 460.7 M |
| SRDX | 24.3 M | 103.9 M | 101.9 M | 104.9 M | 100.2 M | 132.9 M | 136.6 M | 164.1 M | 159.9 M | 168.8 M | 194.6 M | 158.4 M | 185.7 M | 178.6 M | 142.8 M |
| NPCE | 21.1 M | 21.1 M | 21.1 M | 21.1 M | 21.1 M | 21.1 M | 21.1 M | 21.1 M | 21.1 M | 21.1 M | 56 M | 133.6 M | 114.1 M | 107.7 M | 95.1 M |
| CLPT | 3 M | 3 M | 5.6 M | 7.9 M | 13.4 M | 10.1 M | 7.4 M | 13.9 M | 7.9 M | 11.9 M | 29.6 M | 65.6 M | 55.5 M | 42.7 M | 23.2 M |
| TELA | 15.5 M | 15.5 M | 15.5 M | 15.5 M | 15.5 M | 15.5 M | 15.5 M | 15.5 M | 27.2 M | 67.9 M | 86.5 M | 62.5 M | 67.9 M | 78 M | 63.7 M |
| CVRX | 29.1 M | 29.1 M | 29.1 M | 29.1 M | 29.1 M | 29.1 M | 29.1 M | 29.1 M | 29.1 M | 29.1 M | 64.8 M | 152.5 M | 124.9 M | 115.2 M | 107.1 M |
| OFIX | 36.5 M | 695.6 M | 504.3 M | 427.1 M | 393.2 M | 400.2 M | 372.1 M | 405.4 M | 466.6 M | 495.6 M | 525.9 M | 476.6 M | 458.6 M | 925.3 M | 971.6 M |
| AORT | 10.9 M | 147.9 M | 157.2 M | 174.7 M | 176.2 M | 181.2 M | 316.1 M | 591.7 M | 571.1 M | 605.7 M | 789.4 M | 793.1 M | 762.8 M | 792.4 M | 832 M |
| FNA | 74.6 M | 74.6 M | 74.6 M | 74.6 M | 74.6 M | 74.6 M | 74.6 M | 74.6 M | 74.6 M | 74.6 M | 97.6 M | 234.5 M | 254.1 M | 340.7 M | 220.3 M |
| INGN | 24.1 M | 24.1 M | 47.6 M | 82.4 M | 140.1 M | 161.3 M | 214 M | 275.1 M | 375.9 M | 447.3 M | 461.9 M | 489.5 M | 405 M | 326.2 M | 292 M |
| LUNG | 105 K | 105 K | 105 K | 105 K | 473.7 K | 1 M | 578 K | 1.5 M | 15 M | 53.5 M | 263.7 M | 235.2 M | 193.7 M | 177.8 M | 94.3 M |
| APYX | 3.6 M | 28.2 M | 28.2 M | 33.2 M | 24.8 M | 31.4 M | 35.1 M | 31 M | 95.6 M | 84.7 M | 74.1 M | 68.7 M | 51.8 M | 79.2 M | 83.2 M |
Cytosorbents Crp and related stocks such as ProSomnus, Common Stock, LivaNova PLC, and Electromed Total Assets description
Total assets refers to the total amount of Cytosorbents Crp assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Cytosorbents Crp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.My Equities
My Current Equities and Potential Positions
| Cytosorbents Crp | CTSO |
Specialization | Health Care, Health Care Equipment & Services |
| Location | New Jersey; U.S.A |
| Exchange | NASDAQ Exchange |
USD 0.93
Check out Cytosorbents Crp Performance and Cytosorbents Crp Correlation. To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Cytosorbents Crp technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.